CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 36 enrolled
Drug / intervention
sinus lift +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05500911
NCT05500911N/ACompleted

Evaluation of a Bioactive Surface in Posterior Maxillary Sites: Controlled Clinical Trial

Studio Odontoiatrico Associato Dr. P. Cicchese e L. Canullo·interventional·Posted Aug 15, 2022·Updated May 16, 2024

In Brief

A clinical study evaluating sinus lift and implant placement for Edentulous; Alveolar Process, Atrophy and Edentulous Alveolar Ridge Atrophy. Completed, enrolled 36 participants across 1 site.

Detailed Summary

In this controlled clinical study, a maxillary sinus lift (crestal approach) with OSSIX® Bone will be performed, and then implants MultiNeO CS (control group) and NINA MultiNeO NH (test group) will be inserted in edentulous posterior maxillae of study subjects. .+the clinical and radiographic results of the rehabilitation of posterior edentulous maxillary areas, obtained with traditional surface implants (MultiNeO CS, control group), are compared with those obtained with bioactive surface implants (NINA - MultiNeO NH, test group ).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedAug 15, 2022
Enrollment StartApr 22, 2022
Primary CompletionMay 1, 2024
Study CompletionMay 10, 2024
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 3.9 years ago

Interventions

sinus liftprocedure

when residual bone height is \>4 mm sinus lift through crestal approach procedure will be performed and after sinus flor elevation, OSSIX® Bone will be placed in the sinus cavity.

implant placementprocedure

Implant will be placed in edentulous area